Hira S Mian

51PUBLICATIONS
165CO-AUTHORS
Medical mycologyNuclear physicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Liquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (51)

|Oct 02, 2026
Linvoseltamab outcomes by frailty status in patients with relapsed/refractory multiple myeloma: a subgroup analysis of the LINKER-MM1 study.

|Jul 22, 2026
International Myeloma Working Group Recommendations for the Diagnosis and Management of Solitary Plasmacytomas.

|Jun 17, 2026
Practical Management of Bispecific Antibodies in Multiple Myeloma.

|May 20, 2026
Treatment of Multiple Myeloma: ASCO Living Guideline, Version 2026.1.1.

|Apr 14, 2026
Safety and efficacy of ciltacabtagene autoleucel for relapsed/refractory multiple myeloma: a CIBMTR study.

Doris K Hansen, Danai Dima, Hira Mian

|Feb 24, 2026
Early mortality with bispecific antibody therapy in RRMM: an IMWG immunotherapy database real-world analysis.

Carlyn Rose Tan, Saad Z Usmani, Andriy Derkach

Pageof 9

Frequent Collaborators

10 joint publications

Alissa Visram

8 joint publications

Arleigh McCurdy

8 joint publications

Shaji Kumar

8 joint publications

Rahul Banerjee